What Is Technology Transfer?

Tuesday, September 20, 2016

The NCI Technology Transfer Center (TTC) facilitates partnerships between NIH research laboratories and external partners. With a team of technology transfer specialists, NCI TTC guides interactions from discovery to patenting, as well as from collaboration and invention development to licensing.

Tags:

A Helping Hand in the Frederick Community—Ross Smith

Wednesday, September 7, 2016

By day, Ross Smith is the compliance and security officer for Data Management Services, Inc., assigned to the National Cancer Institute (NCI) at Frederick. His role is to ensure the secure operation of in-house computer systems, servers, and network connections. But in his spare time, Smith is also a volunteer firefighter and emergency medical technician (EMT).

Tags:

WHK Interns Dominate Student Jeopardy Tournament

Friday, September 2, 2016

A field of study that derives its name from the Latin root for “knowledge”—student interns had a shot at that clue for 200 points in the 10th annual Student Science Jeopardy Tournament, but their minds went blank. Answer: What is Science?

Tags:

Platinum Publications, July 1–July 28, 2016

Thursday, September 1, 2016

Platinum Publications are selected from articles by NCI at Frederick scientists published in 42 prestigious science journals. This list represents articles published during the time period shown above, as generated from PubMed. Articles designated as Platinum Highlights are noteworthy articles selected by Dr. Craig Reynolds, associate director, National Cancer Institute, from among the most recently published Platinum Publications.

Tags:

Zika Phase I Clinical Trial Material—From Research to Release in 90 Days

Wednesday, August 31, 2016

Over the past 12 months, we’ve grown accustomed to seeing Zika in the news. The virus has been linked to thousands of cases of microcephaly in Brazilian babies. Numerous countries, including the United States, have reported Zika-related deaths. And there is no vaccine available at this time. In the face of what has become a global health crisis, the Vaccine Research Center (VRC) at the NIH/National Institute of Allergy and Infectious Diseases (NIAID) responded to a call from Anthony Fauci, Ph.D., head, NIAID, to get a candidate vaccine into human trials by the summer of 2016.

Tags: